Derek Yuan is a Partner at LYFE Capital, where he applies over 15 years of life sciences research and investment experience. He leverages his Ph. D. from The Rockefeller University and prior experience at Credit Suisse to lead therapeutic investments and guide portfolio companies from early stages to IPO or acquisition.
He holds Series 7, 63, 86, and 87 FINRA certifications, a unique combination of deep scientific expertise and advanced financial qualifications.
Read the full overview →They prefer to do logical analysis and value evidence over emotions. Unless the value is proven by data, they are unlikely to value fancy features. It is very likely that they will negotiate pricing or other important terms.
Calculativeness (C) reflects the degree to which a person is likely to be cautious, systematic and analytical. Those scoring high tend to emphasise quality and accuracy.
Discover additional public profiles from our index.
Looking for someone else? Search here for anyone.